169 related articles for article (PubMed ID: 1752317)
1. Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors.
Piacibello W; Ferrero D; Sanavio F; Badoni R; Stacchini A; Severino A; Aglietta M
Exp Hematol; 1991 Dec; 19(11):1084-9. PubMed ID: 1752317
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
3. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
[TBL] [Abstract][Full Text] [Related]
4. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
5. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
7. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.
Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M
Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165
[TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factor.
Pelus LM; Ottmann OG; Nocka KH
J Immunol; 1988 Jan; 140(2):479-84. PubMed ID: 3121745
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro.
Zucali JR; Broxmeyer HE; Gross MA; Dinarello CA
J Immunol; 1988 Feb; 140(3):840-4. PubMed ID: 3276782
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.
Murphy M; Perussia B; Trinchieri G
Exp Hematol; 1988 Feb; 16(2):131-8. PubMed ID: 3123270
[TBL] [Abstract][Full Text] [Related]
12. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis.
Aglietta M; Stacchini A; Severino A; Sanavio F; Ferrando ML; Piacibello W
Exp Hematol; 1989 Mar; 17(3):296-9. PubMed ID: 2783914
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
Bonnet D; Lemoine FM; Najman A; Guigon M
Exp Hematol; 1995 Jun; 23(6):551-6. PubMed ID: 7539383
[TBL] [Abstract][Full Text] [Related]
14. Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factor.
Hahn T; Shulman LM; Ben-Hur H; Karov Y; Barak V; Handgretinger R; Barak Y
Exp Hematol; 1994 Feb; 22(2):114-21. PubMed ID: 8299733
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha.
Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW
J Cell Biochem; 1989 Feb; 39(2):107-15. PubMed ID: 2715197
[TBL] [Abstract][Full Text] [Related]
16. Immunological separation of two CFU-GM subsets showing different responsiveness to T-cell derived growth factors.
Tarella C; Ferrero D; Caracciolo D; Badoni R; Bellone G; Gallo E
J Clin Lab Immunol; 1988 Apr; 25(4):185-90. PubMed ID: 3262763
[TBL] [Abstract][Full Text] [Related]
17. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
[TBL] [Abstract][Full Text] [Related]
18. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
Roodman GD; Bird A; Hutzler D; Montgomery W
Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
[TBL] [Abstract][Full Text] [Related]
20. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
Canque B; Camus S; Yagello M; Gluckman JC
Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
